Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis
Objective: Buyang Huanwu Decoction (BYHW), a famous herbal prescription in traditional Chinese medicine (TCM), has been used for 200 years for treating ischemic heart failure (IHF). This study aims to assess the efficacy and safety of BYHW combined with guideline-guided pharmacotherapy in patients w...
Saved in:
Main Authors: | Mingjun Zhu (Author), Jingjing Wei (Author), Ying Li (Author), Yongxia Wang (Author), Junguo Ren (Author), Bin Li (Author), Bo Ma (Author), Xinlu Wang (Author), Lijie Qiao (Author), Cheng Zhou (Author), Jianxun Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic evaluation and re-evaluation of buyang huanwu decoction in treating ischemic stroke
by: Da-yuan Zhong, et al.
Published: (2022) -
Buyang Huanwu decoction facilitates neurorehabilitation through an improvement of synaptic plasticity in cerebral ischemic rats
by: Ruihuan Pan, et al.
Published: (2017) -
Effect and mechanism of Buyang Huanwu decoction on retinal inflammation in streptozotocin-induced diabetic rats
by: Wencan LI, et al.
Published: (2022) -
Efficacy evaluation of Buyang Huanwu Decoction in the treatment of ischemic stroke in the recovery period: A systematic review of randomized controlled trials
by: Raoqiong Wang, et al.
Published: (2022) -
Buyang Huanwu Decoction alleviates cerebral ischemic injury through modulating caveolin-1-mediated mitochondrial quality control
by: Yaqian Xu, et al.
Published: (2023)